Clinical Trial Update: Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of selumetinib in adults with hepatocellular carcinoma has completed; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Selumetinib (selumetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-06